stsp-0601
Animal productexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Jan 15, 2020 (NCT04747964)
Timeline
Indications
Studied for
Mechanism of action
- Coagulation factor XACTIVATOR
F10 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06922045 | Phase 3 | Mar 26, 2025 | Chinese Academy of Medical Sciences, Government of China |
| NCT06289166 | Phase 2 | Mar 18, 2024 | Chinese Academy of Medical Sciences, Staidson (Beijing) Biopharmaceuticals Co., Ltd |
| NCT05619926 | Phase 2 | Dec 31, 2022 | Beijing Novikang Medical Technology Co., LTD, Chinese Academy of Medical Sciences, Staidson (Beijing) Biopharmaceuticals Co., Ltd |
| NCT05027230 | Phase 1/Phase 2 (Phase 2) | Oct 18, 2021 | Staidson (Beijing) Biopharmaceuticals Co., Ltd |
| NCT04747964 | Phase 1 | Jan 15, 2020 | China Academy of Chinese Medical Sciences, Staidson (Beijing) Biopharmaceuticals Co., Ltd |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Staidson (Beijing) Biopharmaceuticals Co., Ltd | For profit | 4 | 4 | 2 | 2020 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 3 | 0 | 2 | 2022 |
| Beijing Novikang Medical Technology Co., LTD | For profit | 1 | 0 | 1 | 2022 |
| China Academy of Chinese Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Government of China | Government | 1 | 1 | 1 | 2025 |
5 organizations
Page 1 / 1